Read More 1 minute read Funding News News Qlaris Bio Secures $24M in Series B Funding for Eye Disease Treatment Key Highlights $24 million Series B funding co-led by Canaan and New Leaf Venture Partners. Funds to support Phase II trials of… byChris-Anne RoqueMay 1, 2024